Cerebrospinal biomarker test can detect Alzheimer’s pathology earlier, study shows

Years before tau tangles show up in brain scans of patients with Alzheimer’s disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms that litter the brain, cerebrospinal fluid and potentially blood, new research published today in Nature Medicine suggests.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup